Participation of leukotriene C4 in the regulation of suicidal erythrocyte death

Journal of Physiology and Pharmacology

Volumn 60, Issue 3, 2009, Pages 135-143

  Foller, M ^a   Mahmud, H ^a   Gu, S ^a   Wang, K ^a   Floride, E ^a   Kucherenko, Y ^a   Luik, S ^a   Laufer, S ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Calcium; cysLT1; Eryptosis; Phosphatidylserine

Indexed keywords

1 [3 [3 (4 FLUOROPHENYL)PHENOXY] 1 METHYLALLYL] 1 HYDROXYUREA; CALCIUM ION; CASPASE 3; CASPASE 8; CINALUKAST; GLUCOSE; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR CYSLT1; LIPOCORTIN 5; LIPOXYGENASE INHIBITOR; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG; CALCIUM; DRUG DERIVATIVE; HYDROXYUREA; LEUKOTRIENE D4 RECEPTOR; THIAZOLE DERIVATIVE;

ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL VOLUME; ERYTHROCYTE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CELL SIZE; CONFOCAL MICROSCOPY; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ERYTHROCYTE MEMBRANE; METABOLISM; PHYSIOLOGY;

BLOTTING, WESTERN; CALCIUM; CASPASE 3; CASPASE 8; CELL CULTURE TECHNIQUES; CELL DEATH; CELL SIZE; CELLS, CULTURED; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; GLUCOSE; HUMANS; HYDROXYUREA; LEUKOTRIENE C4; MICROSCOPY, CONFOCAL; PHOSPHATIDYLSERINES; RECEPTORS, LEUKOTRIENE; THIAZOLES;

EID: 70350236408     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. Klarl BA, Lang PA, Kempe DS, et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006; 290: C244-C253.
2. Lang KS, Lang PA, Bauer C, et al. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005; 15: 195-202.
3. Bernhardt I, Weiss E, Robinson HC, Wilkins R, Bennekou P. Differential effect of HOE642 on two separate monovalent cation transporters in the human red cell membrane. Cell Physiol Biochem 2007; 20: 601-606. (Pubitemid 47340620)
4. Foller M, Kasinathan RS, Koka S, et al. TRPC6 contributes to the Ca2+ leak of human erythrocytes. Cell Physiol Biochem 2008; 21: 183-192.
5. Kaestner L, Christophersen P, Bernhardt I, Bennekou P. The non-selective voltage-activated cation channel in the human red blood cell membrane: reconciliation between two conflicting reports and further characterisation. Bioelectrochemistry 2000; 52: 117-125. (Pubitemid 30838523)
6. Kaestner L, Bernhardt I. Ion channels in the human red blood cell membrane: their further investigation and physiological relevance. Bioelectrochemistry 2002; 55: 71-74. (Pubitemid 34084755)
7. Lang KS, Duranton C, Poehlmann H, et al. Cation channels trigger apoptotic death of erythorcytes. Cell Death Differ 2003; 10: 249-256. (Pubitemid 36553467)
8. Lang KS, Myssina S, Tanneur V, et al. Inhibition of erythrocyte cation channels and apoptosis by ethylisopropylamiloride. Naunyn Schmiedebergs Arch Pharmacol 2003; 367: 391-396. (Pubitemid 36535307)
9. Lang PA, Kempe DS, Myssina S, et al. PGE2 in the regulation of programmed erythrocyte death. Cell Death Differ 2005; 12: 415-428. (Pubitemid 40662840)
10. Bautz F, Denzlinger C, Kanz L, Mohle R. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. Blood 2001; 97: 3433-3440.
11. Mohle R, Bautz F, Denzlinger C, Kanz L. Transendothelial migration of hematopoietic progenitor cells. Role of chemotactic factors. Ann N Y Acad Sci 2001; 938: 26-34. (Pubitemid 32620015)
12. Xue X, Cai Z, Seitz G, Kanz L, Weisel KC, Mohle R. Differential effects of G protein coupled receptors on hematopoietic progenitor cell growth depend on their signaling capacities. Ann N Y Acad Sci 2007; 1106: 180-189. (Pubitemid 47443050)
13. Fitzpatrick F, Liggett W, McGee J, Bunting S, Morton D, Samuelsson B. Metabolism of leukotriene A4 by human erythrocytes. A novel cellular source of leukotriene B4. J Biol Chem 1984; 259: 11403-11407. (Pubitemid 14010024)
14. McGee J, Fitzpatrick F. Enzymatic hydration of leukotriene A4. Purification and characterization of a novel epoxide hydrolase from human erythrocytes. J Biol Chem 1985; 260: 12832-12837. (Pubitemid 16230580)
15. Orning L, Jones DA, Fitzpatrick FA. Mechanism-based inactivation of leukotriene A4 hydrolase during leukotriene B4 formation by human erythrocytes. J Biol Chem 1990; 265: 14911-14916. (Pubitemid 20296185)
16. Ballerini P, Di Iorio P, Ciccarelli R, et al. P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia. Int J Immunopathol Pharmacol 2005; 18: 255-268. (Pubitemid 40825888)
17. Capra V, Accomazzo MR, Ravasi S, et al. Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells. Prostaglandins Other Lipid Mediat 2003; 71: 235-251. (Pubitemid 36929793)
18. Capra V, Ravasi S, Accomazzo MR, Parenti M, Rovati GE. CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras. Biochem Pharmacol 2004; 67: 1569-1577. (Pubitemid 38388219)
19. Gauvreau GM, Plitt JR, Baatjes A, MacGlashan DW. Expression of functional cysteinyl leukotriene receptors by human basophils. J Allergy Clin Immunol 2005; 116: 80-87. (Pubitemid 40909752)
20. Hoffmann EK. Leukotriene D4 (LTD4) activates charybdotoxin-sensitive and -insensitive K+ channels in ehrlich ascites tumor cells. Pflugers Arch 1999; 438: 263-268.
21. Lotzer K, Spanbroek R, Hildner M, et al. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenasedependent circuits of inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 2003; 23: e32-e36.
22. Lynch KR, O'Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999; 399: 789-793. (Pubitemid 29293175)
23. Mellor EA, Maekawa A, Austen KF, Boyce JA. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci USA 2001; 98: 7964-7969. (Pubitemid 32642670)
24. Mollerup J, Jorgensen ST, Hougaard C, Hoffmann EK. Identification of a murine cysteinyl leukotriene receptor by expression in Xenopus laevis oocytes. Biochim Biophys Acta 2001; 1517: 455-459. (Pubitemid 32126601)
25. Nielsen CK, Massoumi R, Sonnerlind M, Sjolander A. Leukotriene D4 activates distinct G-proteins in intestinal epithelial cells to regulate stress fibre formation and to generate intracellular Ca2+ mobilisation and ERK1/2 activation. Exp Cell Res 2005; 302: 31-39. (Pubitemid 39482366)
26. Thivierge M, Stankova J, Rola-Pleszczynski M. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells. J Allergy Clin Immunol 2006; 117: 1155-1162.
27. Yang G, Haczku A, Chen H, et al. Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4. Am J Physiol Lung Cell Mol Physiol 2004; 286: L992-L1001. (Pubitemid 38508810)
28. Chang WC, Parekh AB. Close functional coupling between Ca2+ release-activated Ca2+ channels, arachidonic acid release, and leukotriene C4 secretion. J Biol Chem 2004; 279: 29994-29999.
29. Chang WC, Di Capite J, Singaravelu K, Nelson C, Halse V, Parekh AB. Local Ca2+ influx through Ca2+ release-activated Ca2+ (CRAC) channels stimulates production of an intracellular messenger and an intercellular proinflammatory signal. J Biol Chem 2008; 283: 4622-4631.
30. Penzo D, Petronilli V, Angelin A, et al. Arachidonic acid released by phospholipase A2 activation triggers Ca2+- dependent apoptosis through the mitochondrial pathway. J Biol Chem 2004; 279: 25219-25225. (Pubitemid 38756773)
31. Shin HS, Chin MR, Kim JS, et al. Purification and characterization of a cytosolic, 42-kDa and Ca2+-dependent phospholipase A2 from bovine red blood cells: its involvement in Ca2+-dependent release of arachidonic acid from mammalian red blood cells. J Biol Chem 2002; 277: 21086-21094.
32. Maehr H, Yang R. A convergent synthesis of Ro2 4-5913, a novel leukotriene D4 antagonist. Tetrahedron Lett 2008; 37: 5445-5448.
33. Werz O, Steinhilber D. Therapeutic options for 5- lipoxygenase inhibitors. Pharmacol Ther 2006; 112: 701-718.
34. Attanasio P, Shumilina E, Hermle T, et al. Stimulation of eryptosis by anti-A IgG antibodies. Cell Physiol Biochem 2007; 20: 591-600. (Pubitemid 47340619)
35. Nicolay JP, Gatz S, Liebig G, Gulbins E, Lang F. Amyloid induced suicidal erythrocyte death. Cell Physiol Biochem 2007; 19: 175-184. (Pubitemid 46270900)
36. Bentzen PJ, Lang F. Effect of anandamide on erythrocyte survival. Cell Physiol Biochem 2007; 20: 1033-1042.
37. Bentzen PJ, Lang E, Lang F. Curcumin induced suicidal erythrocyte death. Cell Physiol Biochem 2007; 19: 153-164. (Pubitemid 46270898)
38. Foller M, Shumilina E, Lam R, et al. Induction of suicidal erythrocyte death by listeriolysin from Listeria monocytogenes. Cell Physiol Biochem 2007; 20: 1051-1060. (Pubitemid 350059711)
39. Duranton C, Huber SM, Lang F. Oxidation induces a Cl(-)- dependent cation conductance in human red blood cells. J Physiol 2002; 539: 847-855. (Pubitemid 35175434)
40. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003; 285: C1553-C1560.
41. Berg CP, Engels IH, Rothbart A, et al. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001; 8: 1197-1206. (Pubitemid 34048474)
42. Bratosin D, Estaquier J, Petit F, et al. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001; 8: 1143-1156. (Pubitemid 34048470)
43. Di Capite J, Shirley A, Nelson C, Bates G, Parekh AB. Intercellular Ca2+ wave propagation involving positive feedback between CRAC channels and cysteinyl leukotrienes. FASEB J 2009; 23: 894-905.
44. Chang WC, Parekh AB. Close functional coupling between Ca2+ release-activated Ca2+ channels, arachidonic acid release, and leukotriene C4 secretion. J Biol Chem 2004; 279: 29994-29999.
45. Chang WC, Nelson C, Parekh AB. Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c-fos through ERK-dependent and -independent pathways in mast cells. FASEB J 2006; 20: 2381-2383.
46. Gorenne I, Labat C, Gascard JP, Norel X, Nashashibi N, Brink C. Leukotriene D4 contractions in human airways are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry. J Pharmacol Exp Ther 1998; 284: 549-552. (Pubitemid 28086640)
47. Snetkov VA, Hapgood KJ, McVicker CG, Lee TH, Ward JP. Mechanisms of leukotriene D4-induced constriction in human small bronchioles. Br J Pharmacol 2001; 133: 243-252.
48. Subramanian N. Leukotriene B4 induced steady state calcium rise and superoxide anion generation in guinea pig eosinophils are not related events. Biochem Biophys Res Commun 1992; 187: 670-676.
49. Costa-Junior HM, Mendes AN, Davis GH, et al. ATPinduced apoptosis involves a Ca2+-independent phospholipase A2 and 5-lipoxygenase in macrophages. Prostaglandins Other Lipid Mediat 2009; 88: 51-61.
50. Hoffmann EK, Lambert IH, Simonsen LO. Mechanisms in volume regulation in Ehrlich ascites tumor cells. Ren Physiol Biochem 1988; 11: 221-247. (Pubitemid 19059469)
51. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552-565. (Pubitemid 36773407)
52. Claria J. Regulation of cell proliferation and apoptosis by bioactive lipid mediators. Recent Pat Anticancer Drug Discov 2006; 1: 369-382.
53. Moreno JJ. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem Pharmacol 2009; 77: 1-10.
54. Phillis JW, Horrocks LA, Farooqui AA. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev 2006; 52: 201-243.
55. Sheng WW, Li CT, Zhang WP, et al. Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death. Biochem Biophys Res Commun 2006; 346: 19-25.
56. Goto HG, Nishizawa Y, Katayama H, et al. Induction of apoptosis in an estrogen-responsive mouse Leydig tumor cell by leukotriene. Oncol Rep 2007; 17: 225-232.
57. Paruchuri S, Mezhybovska M, Juhas M, Sjolander A. Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells. Oncogene 2006; 25: 6660-6665. (Pubitemid 44646193)
58. Melstrom LG, Bentrem DJ, Salabat MR, et al. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res 2008; 14: 6525-6530.
59. Ihara A, Wada K, Yoneda M, Fujisawa N, Takahashi H, Nakajima A. Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. J Pharmacol Sci 2007; 103: 24-32. (Pubitemid 46175592)
60. Kleban J, Szilardiova B, Mikes J, et al. Pre-treatment of HT- 29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin. J Photochem Photobiol B 2006; 84: 79-88.
61. Tavolari S, Bonafe M, Marini M, et al. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. Carcinogenesis 2008; 29: 371-380. (Pubitemid 351359677)
62. Matsuyama M, Hayama T, Funao K, et al. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis. Oncol Rep 2007; 18: 99-104.
63. Sveinbjornsson B, Rasmuson A, Baryawno N, et al. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. FASEB J 2008; 22: 3525-3536.
64. Schneider J, Nicolay JP, Foller M, Wieder T, Lang F. Suicidal erythrocyte death following cellular K+ loss. Cell Physiol Biochem 2007; 20: 35-44. (Pubitemid 46956810)
65. Nunomura W, Takakuwa Y, Tokimitsu R, Krauss SW, Kawashima M, Mohandas N. Regulation of CD44-protein 4.1 interaction by Ca2+ and calmodulin. Implications for modulation of CD44-ankyrin interaction. J Biol Chem 1997; 272: 30322-30328. (Pubitemid 27512238)
66. Takakuwa Y, Mohandas N. Modulation of erythrocyte membrane material properties by Ca2+ and calmodulin. Implications for their role in regulation of skeletal protein interactions. J Clin Invest 1988; 82: 394-400. (Pubitemid 18213737)
67. Anderson DR, Davis JL, Carraway KL. Calcium-promoted changes of the human erythrocyte membrane. Involvement of spectrin, transglutaminase, and a membrane-bound protease. J Biol Chem 1977; 252: 6617-6623.
68. Allan D, Billah MM, Finean JB, Michell RH. Release of diacylglycerol-enriched vesicles from erythrocytes with increased intracellular (Ca2+). Nature 1976; 261: 58-60.
69. Cohen CM, Gascard P. Regulation and post-translational modification of erythrocyte membrane and membraneskeletal proteins. Semin Hematol 1992; 29: 244-292.
70. Minetti G, Piccinini G, Balduini C, Seppi C, Brovelli A. Tyrosine phosphorylation of band 3 protein in Ca2+/A23187-treated human erythrocytes. Biochem J 1996; 320(Pt 2): 445-450. (Pubitemid 126731804)
71. Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci USA 1998; 95: 3077-3081. (Pubitemid 28135857)
72. Kempe DS, Lang PA, Duranton C, et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006; 20: 368-370. (Pubitemid 46671174)
73. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999; 6: 76-82. (Pubitemid 29342520)
74. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999; 107: 300-302. (Pubitemid 29530214)
75. Zappulla D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J Cardiometab Syndr 2008; 3: 30-34.
76. Haeggstrom JZ, Wetterholm A. Enzymes and receptors in the leukotriene cascade. Cell Mol Life Sci 2002; 59: 742-753.
77. Hedqvist P, Gautam N, Lindbom L. Interactions between leukotrienes and other inflammatory mediators/modulators in the microvasculature. Am J Respir Crit Care Med 2000; 161: S117-S119. (Pubitemid 30129428)
78. Jawien J, Gajda M, Olszanecki R, Korbut R. BAY x 1005 attenuates atherosclerosis in apoE/L. J Physiol Pharmacol 2007; 58: 583-588.
79. Jawien J, Gajda M, Wolkow P, Zuranska J, Olszanecki R, Korbut R. The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice. J Physiol Pharmacol 2008; 59: 633-639.
80. Head DJ, Lee ZE, Poole J, Avent ND. Expression of phosphatidylserine (PS) on wild-type and Gerbich variant erythrocytes following glycophorin-C (GPC) ligation. Br J Haematol 2005; 129: 130-137. (Pubitemid 40524061)
81. Head DJ, Lee ZE, Swallah MM, Avent ND. Ligation of CD47 mediates phosphatidylserine expression on erythrocytes and a concomitant loss of viability in vitro. Br J Haematol 2005; 130: 788-790.
82. Mandal D, Mazumder A, Das P, Kundu M, Basu J. FAS-, caspase 8- and caspase 3-dependent signaling regulate the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J Biol Chem 2005; 280: 39460-39467. (Pubitemid 41713903)
83. Foller M, Huber SM, Lang F. Erythroycte programmed cell death. IUBMB Life 2008; 60: 661-668.
84. Lang F, Gulbins E, Lerche H, Huber SM, Kempe DS, Foller M. Eryptosis, a window to systemic disease. Cell Physiol Biochem 2008; 22: 373-380.
85. Niemoeller OM, Foller M, Lang C, Huber SM, Lang F. Retinoic acid induced suicidal erythrocyte death. Cell Physiol Biochem 2008; 21: 193-202.
86. Niemoeller OM, Mahmud H, Foller M, Wieder T, Lang F. Ciglitazone and 15d-PGJ2 induced suicidal erythrocyte death. Cell Physiol Biochem 2008; 22: 237-244.
87. Sopjani M, Foller M, Dreischer P, Lang F. Stimulation of eryptosis by cadmium ions. Cell Physiol Biochem 2008; 22: 245-252.
88. Kempe DS, Akel A, Lang PA, et al. Suicidal erythrocyte death in sepsis. J Mol Med 2007; 85: 269-277.
89. Birka C, Lang PA, Kempe DS, et al. Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004; 448: 471-477.
90. Lang PA, Beringer O, Nicolay JP, et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006; 84: 378-388. (Pubitemid 43673612)
91. Koka S, Lang C, Boini KM, Bobbala D, Huber SM, Lang F. Influence of chlorpromazine on eryptosis, parasitemia and survival of Plasmodium berghe infected mice. Cell Physiol Biochem 2008; 22: 261-268.
92. Koka S, Lang C, Niemoeller OM, et al. Influence of NO synthase inhibitor L-NAME on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2008; 21: 481-488. (Pubitemid 351620302)
93. Lang PA, Schenck M, Nicolay JP, et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007; 13: 164-170. (Pubitemid 46245766)
94. Lang KS, Roll B, Myssina S, et al. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6- phosphate dehydrogenase deficiency. Cell Physiol Biochem 2002; 12: 365-372. (Pubitemid 35356712)
95. Kuypers FA. Membrane lipid alterations in hemoglobinopathies. In: Hematology Am Soc. Hematol. Educ. Program 2007, 68-73.
96. Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM. Apoptotic cells, through transforming growth factor-beta, coordinately induce antiinflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 2006; 281: 38376-38384.
97. Sheng WW, Li CT, Zhang WP, et al. Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death. Biochem Biophys Res Commun 2006; 346: 19-25.
98. Paruchuri S, Mezhybovska M, Juhas M, Sjolander A. Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells. Oncogene 2006; 25: 6660-6665. (Pubitemid 44646193)
99. Sener G, Sakarcan A, Sehirli O, et al. Chronic renal failureinduced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Prostaglandins Other Lipid Mediat 2007; 83: 257-267. (Pubitemid 46710463)
100. Mezhybovska M, Wikstrom K, Ohd JF, Sjolander A. The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells. J Biol Chem 2006; 281: 6776-6784. (Pubitemid 43847614)
101. Berridge MJ. Unlocking the secrets of cell signaling. Annu Rev Physiol 2005; 67: 1-21.
102. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552-565. (Pubitemid 36773407)